166 related articles for article (PubMed ID: 31341961)
21. High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.
Carén H; Erichsen J; Olsson L; Enerbäck C; Sjöberg RM; Abrahamsson J; Kogner P; Martinsson T
BMC Genomics; 2008 Jul; 9():353. PubMed ID: 18664255
[TBL] [Abstract][Full Text] [Related]
22. Frequent homozygous deletions of the CDKN2A locus in somatic cancer tissues.
Hamid A; Petreaca B; Petreaca R
Mutat Res; 2019 May; 815():30-40. PubMed ID: 31096160
[TBL] [Abstract][Full Text] [Related]
23. Homozygous deletion and frequent allelic loss of the 21q11.1-q21.1 region including the ANA gene in human lung carcinoma.
Kohno T; Kawanishi M; Matsuda S; Ichikawa H; Takada M; Ohki M; Yamamoto T; Yokota J
Genes Chromosomes Cancer; 1998 Mar; 21(3):236-43. PubMed ID: 9523199
[TBL] [Abstract][Full Text] [Related]
24. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
25. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.
Konishi H; Sugiyama M; Mizuno K; Saito H; Yatabe Y; Takahashi T; Osada H; Takahashi T
Oncogene; 2003 Mar; 22(12):1892-905. PubMed ID: 12660825
[TBL] [Abstract][Full Text] [Related]
26. Whole-genome analysis of a patient with early-stage small-cell lung cancer.
Han JY; Lee YS; Kim BC; Lee GK; Lee S; Kim EH; Kim HM; Bhak J
Pharmacogenomics J; 2014 Dec; 14(6):503-8. PubMed ID: 24709692
[TBL] [Abstract][Full Text] [Related]
27. Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers.
Olopade OI; Buchhagen DL; Malik K; Sherman J; Nobori T; Bader S; Nau MM; Gazdar AF; Minna JD; Diaz MO
Cancer Res; 1993 May; 53(10 Suppl):2410-5. PubMed ID: 7683574
[TBL] [Abstract][Full Text] [Related]
28. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.
Cairns P; Okami K; King P; Bonacum J; Ahrendt S; Wu L; Mao L; Jen J; Sidransky D
Cancer Res; 1997 Dec; 57(23):5356-9. PubMed ID: 9393760
[TBL] [Abstract][Full Text] [Related]
29. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
30. Characterization of homozygous deletions in laryngeal squamous cell carcinoma cell lines.
Giefing M; Martin-Subero JI; Kiwerska K; Jarmuz M; Grenman R; Siebert R; Szyfter K
Cancer Genet Cytogenet; 2008 Jul; 184(1):38-43. PubMed ID: 18558287
[TBL] [Abstract][Full Text] [Related]
31. A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity.
Daly MC; Xiang RH; Buchhagen D; Hensel CH; Garcia DK; Killary AM; Minna JD; Naylor SL
Oncogene; 1993 Jul; 8(7):1721-9. PubMed ID: 8390035
[TBL] [Abstract][Full Text] [Related]
32. Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis.
Zhao X; Weir BA; LaFramboise T; Lin M; Beroukhim R; Garraway L; Beheshti J; Lee JC; Naoki K; Richards WG; Sugarbaker D; Chen F; Rubin MA; Jänne PA; Girard L; Minna J; Christiani D; Li C; Sellers WR; Meyerson M
Cancer Res; 2005 Jul; 65(13):5561-70. PubMed ID: 15994928
[TBL] [Abstract][Full Text] [Related]
33. Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer.
Picchio MC; Martin ES; Cesari R; Calin GA; Yendamuri S; Kuroki T; Pentimalli F; Sarti M; Yoder K; Kaiser LR; Fishel R; Croce CM
Clin Cancer Res; 2004 Apr; 10(8):2720-4. PubMed ID: 15102676
[TBL] [Abstract][Full Text] [Related]
34. Detection of tumor-specific homozygous deletions in human biopsies by polymerase chain reaction.
Böhm M; Wieland I; Totzeck B
Cancer Genet Cytogenet; 1993 Feb; 65(2):83-7. PubMed ID: 8453608
[TBL] [Abstract][Full Text] [Related]
35. Homozygous deletion of p16INK4a and tobacco carcinogen exposure in nonsmall cell lung cancer.
Kraunz KS; Nelson HH; Lemos M; Godleski JJ; Wiencke JK; Kelsey KT
Int J Cancer; 2006 Mar; 118(6):1364-9. PubMed ID: 16184554
[TBL] [Abstract][Full Text] [Related]
36. Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer.
Gill RK; Yang SH; Meerzaman D; Mechanic LE; Bowman ED; Jeon HS; Roy Chowdhuri S; Shakoori A; Dracheva T; Hong KM; Fukuoka J; Zhang JH; Harris CC; Jen J
Oncogene; 2011 Sep; 30(35):3784-91. PubMed ID: 21532627
[TBL] [Abstract][Full Text] [Related]
37. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
[TBL] [Abstract][Full Text] [Related]
38. CGARS: cancer genome analysis by rank sums.
Lu X; Thomas RK; Peifer M
Bioinformatics; 2014 May; 30(9):1295-6. PubMed ID: 24413525
[TBL] [Abstract][Full Text] [Related]
39. The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer.
Scrima M; De Marco C; De Vita F; Fabiani F; Franco R; Pirozzi G; Rocco G; Malanga D; Viglietto G
Am J Pathol; 2012 Mar; 180(3):1202-1214. PubMed ID: 22245727
[TBL] [Abstract][Full Text] [Related]
40. Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers.
Kohno T; Takahashi M; Manda R; Yokota J
Genes Chromosomes Cancer; 1998 Jun; 22(2):152-6. PubMed ID: 9598803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
